81.99
0.88 (1.08%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Bearish |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | PROCEPT BioRobotics Corporation | Bullish | Bullish |
Stockmoo Score
|
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 99.00 (TD Cowen, 20.75%) | Buy |
| Median | 94.50 (15.26%) | |
| Low | 69.00 (Wells Fargo, -15.84%) | Buy |
| Average | 89.25 (8.86%) | |
| Total | 4 Buy | |
| Avg. Price @ Call | 73.68 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| TD Cowen | 16 Sep 2024 | 99.00 (20.75%) | Buy | 81.99 |
| Truist Securities | 03 Sep 2024 | 95.00 (15.87%) | Buy | 75.06 |
| 02 Aug 2024 | 74.00 (-9.75%) | Buy | 57.38 | |
| B of A Securities | 22 Aug 2024 | 94.00 (14.65%) | Buy | 80.27 |
| Wells Fargo | 02 Aug 2024 | 69.00 (-15.84%) | Buy | 57.38 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| DESAI ANTAL ROHIT | - | 77.31 | -187,002 | -14,530,810 |
| Aggregate Net Quantity | -187,002 | |||
| Aggregate Net Value ($) | -14,530,810 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 77.31 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| DESAI ANTAL ROHIT | Director | 12 Sep 2024 | Automatic sell (-) | 44,867 | 80.39 | 3,606,858 |
| DESAI ANTAL ROHIT | Director | 11 Sep 2024 | Automatic sell (-) | 38,698 | 78.11 | 3,022,701 |
| DESAI ANTAL ROHIT | Director | 10 Sep 2024 | Automatic sell (-) | 36,500 | 76.94 | 2,808,310 |
| DESAI ANTAL ROHIT | Director | 05 Sep 2024 | Automatic sell (-) | 13,305 | 76.35 | 1,015,837 |
| DESAI ANTAL ROHIT | Director | 04 Sep 2024 | Automatic sell (-) | 17,420 | 76.02 | 1,324,268 |
| DESAI ANTAL ROHIT | Director | 04 Sep 2024 | Automatic sell (-) | 36,212 | 76.02 | 2,752,836 |
| Date | Type | Details |
|---|---|---|
| 28 Aug 2024 | Announcement | PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024 |
| 21 Aug 2024 | Announcement | PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy |
| 01 Aug 2024 | Announcement | PROCEPT BioRobotics® Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance |
| 15 Jul 2024 | Announcement | PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |